Interestingly, it has been reported that the non-serotonergic anti-inflammatory effect of FLX potentially has the ability to inhibit IL-6 and NF-κB signaling pathways driving the cytokine storm in COVID-19 [41]. Here, NFKB1 is linked to COVID-19.